Stem Cell Therapies for Cerebral Palsy and Autism Spectrum Disorder-A Systematic Review.
Justyna PaprockaKonrad KaminiówSylwia KozakKarolina SztubaEwa Emich-WideraPublished in: Brain sciences (2021)
Autism spectrum disorder (ASD) and cerebral palsy (CP) are some of the most common neurodevelopmental diseases. They have multifactorial origin, which means that each case may manifest differently from the others. In patients with ASD, symptoms associated with deficits in social communication and characteristic, repetitive types of behaviors or interests are predominant, while in patients with CP, motor disability is diagnosed with accompanying cognitive impairment of various degrees. In order to minimize their adverse effects, it is necessary to promptly diagnose and incorporate appropriate management, which can significantly improve patient quality of life. One of the therapeutic possibilities is stem cell therapy, already known from other branches of medicine, with high hopes for safe and effective treatment of these diseases. Undoubtedly, in the future we will have to face the challenges that will arise due to the still existing gaps in knowledge and the heterogeneity of this group of patients. The purpose of this systematic review is to summarize briefly the latest achievements and advances in stem cell therapy for ASD and CP.
Keyphrases
- autism spectrum disorder
- cerebral palsy
- stem cells
- cell therapy
- intellectual disability
- attention deficit hyperactivity disorder
- systematic review
- cognitive impairment
- end stage renal disease
- healthcare
- chronic kidney disease
- ejection fraction
- multiple sclerosis
- traumatic brain injury
- prognostic factors
- meta analyses
- case report
- randomized controlled trial
- mental health
- mesenchymal stem cells
- high frequency
- patient reported outcomes
- current status
- physical activity
- replacement therapy
- smoking cessation